Search for Andrew Witty and
    1. December 14, 2014

      Academia should place collaboration with industry at its heart

      The vast majority of university and business leaders in the UK would agree that business schools and business should...

    2. December 4, 2014

      GSK drops plan to sell older drugs

      GlaxoSmithKline has ditched plans for a multibillion-pound sale of some of its older medicines, halting an auction that had...

    1. November 17, 2014

      GlaxoSmithKline leads Access to Medicine Index

      GlaxoSmithKline is leading the pharmaceuticals industry in efforts to widen global access to medicines, according to a...

    2. October 24, 2014

      Progress against Aids spurs GSK plan to float ViiV Healthcare

      As the pharmaceuticals industry races to find a cure for Ebola, there was a reminder this week of the medical innovation...

    3. October 23, 2014

      Industry response to Ebola quickens

      Pharmaceutical executives and international donors were thrashing out details of a push to accelerate development of...

    4. October 22, 2014

      Witty riposte will only go some way to pacify drug group’s doubters

      Dull quarterly earnings statements with incremental numbers? Not for Sir Andrew Witty, chief executive of drugs giant...

    5. October 22, 2014

      GSK’s Witty fights back with strong message to shareholders

      After months on the defensive over bribery allegations and declining sales, Wednesday was the day when Sir Andrew Witty...

    6. October 22, 2014

      GSK expects first doses of Ebola vaccine ready by year end

      GlaxoSmithKline said it expected to have the first doses of its experimental Ebola vaccine ready by the end of this year, as...

    7. October 22, 2014

      GSK restructuring to include potential float of HIV unit

      GlaxoSmithKline has launched a multibillion-pound restructuring drive – including a potential flotation of its HIV drugs...

    8. September 25, 2014

      Sir Philip Hampton’s in-tray at GSK

      Sir Philip Hampton has held senior roles at several of Britain’s biggest companies, including BT, J Sainsbury and, most...

    9. September 24, 2014

      GlaxoSmithKline appoints Sir Philip Hampton as chairman

      GlaxoSmithKline on Thursday confirmed Sir Philip Hampton as its next chairman in a move that sees him swap his role as...

    10. September 19, 2014

      GSK to pay £297m fine for Chinese bribes

      GlaxoSmithKline will pay a £297m fine after being found guilty of bribery by a Chinese court – the biggest such penalty...

    11. July 31, 2014

      Drug pricing: Bitter pill

      When delegates turned up for a big healthcare conference at New York’s plush Waldorf Astoria hotel in February, they were...

    12. July 28, 2014

      GSK and Reckitt: pharming out

      Well done Reckitt Benckiser and GlaxoSmithKline. But what took you so long? Both have recognised that pharmaceuticals and...

    13. July 27, 2014

      GSK’s Witty fights back amid bribery scandal and profit warning

      For most of his six years as chief executive of GlaxoSmithKline, Andrew Witty has been the golden boy of British business....

    14. July 27, 2014

      GSK opens issue of spinning off consumer division

      GlaxoSmithKline’s chief executive has opened the possibility of the group being broken up in the future as he pushes through...

    15. July 24, 2014

      GSK investigating Syrian charges

      GlaxoSmithKline is investigating fresh allegations of corruption, this time in Syria, adding to a series of bribery claims...

    16. July 23, 2014

      Longtime GSK favourite stumbles in the final furlong

      The Queen’s horse Estimate, former Gold Cup champion, has failed a drug test, as has GlaxoSmithKline. On Wednesday the group...

    17. July 23, 2014

      GSK cuts guidance as sales and profits slide

      Shares in GlaxoSmithKline fell almost 5 per cent on Wednesday after a profit warning highlighted the UK pharmaceuticals...

    18. June 4, 2014

      GSK pays settlements to 40-plus US states

      GlaxoSmithKline has agreed to pay $105m to more than 40 US states to settle allegations of unlawful marketing, ending a long...

    19. May 29, 2014

      GlaxoSmithKline asks for bids on older drugs list

      GlaxoSmithKline has invited private equity firms to bid for some of its older drugs in the latest step by Sir Andrew Witty,...

    20. April 30, 2014

      GSK plays down prospect of white knight bid for AstraZeneca

      The chief executive of GlaxoSmithKline all but ruled out a white knight bid by the UK pharmaceuticals company for...

    21. April 22, 2014

      Deals fever grips pharmaceuticals industry

      A near $50bn takeover battle for the maker of Botox and a multibillion-dollar asset swap between Novartis and...

    22. April 22, 2014

      Sir Andrew Witty seeks to overcome most difficult year at GSK

      For Sir Andrew Witty, the past year has been the most difficult of his six years as chief executive of GlaxoSmithKline....

    23. April 22, 2014

      GSK chief quick to distance Novartis deal from megamerger mania

      Another day, another big pharma deal. Novartis and GlaxoSmithKline became the latest companies to join the industry’s...

    24. April 22, 2014

      The Joker’s on Quindell

      Holy mackerel, Batman! A shortseller called Gotham City Research has triggered a 40 per cent plunge in the shares of...

    25. April 22, 2014

      Novartis buys GSK business for up to $16bn in restructuring

      Novartis and GlaxoSmithKline have agreed to swap a series of assets in a multibillion-dollar deal that will reshape two of...

    26. April 7, 2014

      Reform of pharma practices should go wider than GSK

      Two cases do not make an epidemic. But it is still serious for GlaxoSmithKline that allegations of bribery have surfaced in...

    27. April 1, 2014

      Drugmakers learn to blend commerce with philanthropy in Africa

      Africa has rarely been a source of good publicity for big pharma. But two events this week suggest the drugs industry is...

    28. February 5, 2014

      GlaxoSmithKline sticks with bet on emerging markets

      GlaxoSmithKline, the UK drugmaker, will press ahead with its big bet on emerging markets, despite turmoil in its scandal-hit...

    29. December 17, 2013

      GSK China probe flags up wider concerns

      Unshaven and dressed in a blue and grey striped T-shirt, Liang Hong looked nondescript on screen. But his words, broadcast...

    30. December 16, 2013

      GSK scraps sales rep targets after scandal

      GlaxoSmithKline is to scrap individual sales targets for its commercial staff as it seeks to repair its image and reform...

    31. December 3, 2013

      Detained couple’s son in call to GSK boss

      The son of a British fraud investigator detained in Shanghai has called on the head of GlaxoSmithKline, the UK drugs company...

    32. December 3, 2013

      David Cameron defends GSK during China trip

      David Cameron has risked angering the Chinese government by launching a robust defence of GlaxoSmithKline as the UK drug...

    33. December 2, 2013

      Spotlight on Cameron’s China delegation

      David Cameron has taken a business delegation of 127 executives with him to China, most of whom will have very little...

    34. November 24, 2013

      SMEs and business schools need closer working links

       Lord Digby Jones – the former head of the CBI, the employers’ body – once said that when it comes to business schools,...

    35. October 23, 2013

      GSK China sales plummet 60% since scandal

      GlaxoSmithKline’s medicine and vaccine sales in China have dropped 61 per cent since the summer, following a high-profile...

    36. October 15, 2013

      Ministers urged to tap university research

      A leading industrialist has urged ministers to commit at least £1bn in the next parliament to university-led projects that...

    37. September 23, 2013

      GlaxoSmithKline China sales face growing pressure

      Sales of GlaxoSmithKline’s medicines in China are thought to have dropped 30 per cent since officials accused the UK...

    38. July 24, 2013

      GSK: in need of a Chinese remedy

      Scandals are, by nature, vague and confusing things. Are things as bad as they look? How long until the fog clears? Since...

    Search for Andrew Witty and